Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $798.2350 (-0.41%) ($792.9100 - $806.0900) on Tue. Nov. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.03% (three month average) | RSI | 56 | Latest Price | $798.2350(-0.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | Weekly Trend | REGN declines -1.2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(46%) SPLV(40%) SDY(39%) XLV(38%) XLF(33%) | Factors Impacting REGN price | REGN will decline at least -0.515% in a week (0% probabilities). VXX(-27%) UNG(-27%) ONLN(-27%) USO(-26%) VIXM(-19%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.515% (StdDev 1.03%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $800.6 | 5 Day Moving Average | $798.04(0.02%) | 10 Day Moving Average | $799.76(-0.19%) | 20 Day Moving Average | $800.6(-0.3%) | To recent high | -5.6% | To recent low | 3% | Market Cap | $84.636b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |